Ashfords advised life sciences company Iksuda Therapeutics on the deal. Bird & Bird advised Mirae Asset Capital, Celltrion and Premier Partners. Iksuda is the developer of...
Iksuda Therapeutics’ £29.6 Million Series A Financing Round
Iksuda Therapeutics’ £29.6 Million Series A Financing Round
Ashfords advised life sciences company Iksuda Therapeutics on the deal. Bird & Bird advised Mirae Asset Capital, Celltrion and Premier Partners. Iksuda is the developer of...
Craven Street Capital’s Acquisition Of Kreston Reeves Financial Planning
Ashfords LLP has advised Craven Street Capital on the deal. Craven Street Capital acquired Kreston Reeves Financial Planning (KRFP), establishing Craven Street Wealth. Based in London, Craven...